These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 6376640)

  • 1. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
    Gammon WR; Inman AO; Wheeler CE
    J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional heterogeneity of immune complexes in epidermolysis bullosa acquisita.
    Gammon WR; Briggaman RA
    J Invest Dermatol; 1987 Nov; 89(5):478-83. PubMed ID: 3668292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo JR
    J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomical distribution and immunological characteristics of epidermolysis bullosa acquisita antigen and bullous pemphigoid antigen.
    Furue M; Iwata M; Tamaki K; Ishibashi Y
    Br J Dermatol; 1986 Jun; 114(6):651-9. PubMed ID: 3521710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin.
    Fine JD
    J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin.
    Gammon WR; Briggaman RA; Inman AO; Queen LL; Wheeler CE
    J Invest Dermatol; 1984 Feb; 82(2):139-44. PubMed ID: 6363567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen.
    Gammon WR; Woodley DT; Dole KC; Briggaman RA
    J Invest Dermatol; 1985 Jun; 84(6):472-6. PubMed ID: 3889170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of extracellular and intracellular bullous pemphigoid antigens at the dermal-epibolic junction in organ culture of human skin.
    Ikeda S; Yaguchi H; Ogawa H
    J Invest Dermatol; 1990 Mar; 94(3):336-40. PubMed ID: 2407787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid.
    Mooney E; Falk RJ; Gammon WR
    Arch Dermatol; 1992 Jan; 128(1):58-60. PubMed ID: 1371212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of bullous pemphigoid antibody--an indirect immunofluorescence study of 228 cases using a split-skin technique.
    Logan RA; Bhogal B; Das AK; McKee PM; Black MM
    Br J Dermatol; 1987 Oct; 117(4):471-8. PubMed ID: 3314971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermolysis bullosa acquisita--a pemphigoid-like disease.
    Gammon WR; Briggaman RA; Woodley DT; Heald PW; Wheeler CE
    J Am Acad Dermatol; 1984 Nov; 11(5 Pt 1):820-32. PubMed ID: 6392361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basement membrane reactivity of antisera to type IV collagen and sera from patients with bullous pemphigoid and epidermolysis bullosa acquisita.
    Peng TK; Nisengard RJ; Levine MJ; Beutner EH
    Proc Natl Sci Counc Repub China B; 1984 Jul; 8(3):268-73. PubMed ID: 6400590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Carlo JR; Wheeler CE
    J Invest Dermatol; 1982 Apr; 78(4):285-90. PubMed ID: 7040558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
    Gomes MA; Dambuyant C; Thivolet J; Bussy R
    Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte chemotaxis to the dermal-epidermal junction of human skin mediated by pemphigoid antibody and complement: mechanism of cell attachment in the in vitro leukocyte attachment method.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo J
    J Invest Dermatol; 1981 Jun; 76(6):514-22. PubMed ID: 7017015
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement.
    Iwatsuki K; Tagami H; Yamada M
    Acta Derm Venereol; 1983; 63(4):290-5. PubMed ID: 6195859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases.
    Woźniak K; Kowalewski C
    J Dermatol Sci; 2005 Dec; 40(3):169-75. PubMed ID: 15990279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin.
    Gammon WR; Lewis DM; Carlo JR; Sams WM; Wheeler CE
    J Invest Dermatol; 1980 Oct; 75(4):334-9. PubMed ID: 7000926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid).
    Briggaman RA; Gammon WR; Woodley DT
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):79s-84s. PubMed ID: 4008982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses.
    Jenkins RE; Rodenas J; Bhogal BS; Black MM
    Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.